Found: 7
Select item for more details and to access through your institution.
19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML).
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 23, p. 14586, doi. 10.3390/ijms232314586
- By:
- Publication type:
- Article
Energy metabolism and drug response in myeloid leukaemic stem cells.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 4, p. 524, doi. 10.1111/bjh.16074
- By:
- Publication type:
- Article
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 12, p. 1, doi. 10.1002/ctm2.1146
- By:
- Publication type:
- Article
Racial/ethnic differences in the clinical presentation and survival of breast cancer by subtype.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1443399
- By:
- Publication type:
- Article
26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 9, p. 2390, doi. 10.3390/cells10092390
- By:
- Publication type:
- Article
Blood cancer health disparities in the United States Hispanic population.
- Published in:
- Cold Spring Harbor Molecular Case Studies, 2021, v. 7, n. 2, p. 1, doi. 10.1101/mcs.a005967
- By:
- Publication type:
- Article
Ethnic and border differences on blood cancer presentation and outcomes: A Texas population‐based study.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 7, p. 1068, doi. 10.1002/cncr.33347
- By:
- Publication type:
- Article